Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis. / Aasbjerg, Kristian; Torp-Pedersen, C; Backer, V.

I: Allergy: European Journal of Allergy and Clinical Immunology, Bind 67, Nr. 11, 2012, s. 1423-9.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Aasbjerg, K, Torp-Pedersen, C & Backer, V 2012, 'Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis', Allergy: European Journal of Allergy and Clinical Immunology, bind 67, nr. 11, s. 1423-9. https://doi.org/10.1111/all.12023

APA

Aasbjerg, K., Torp-Pedersen, C., & Backer, V. (2012). Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology, 67(11), 1423-9. https://doi.org/10.1111/all.12023

Vancouver

Aasbjerg K, Torp-Pedersen C, Backer V. Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology. 2012;67(11):1423-9. https://doi.org/10.1111/all.12023

Author

Aasbjerg, Kristian ; Torp-Pedersen, C ; Backer, V. / Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis. I: Allergy: European Journal of Allergy and Clinical Immunology. 2012 ; Bind 67, Nr. 11. s. 1423-9.

Bibtex

@article{b5f77862d51640ed8b933361740d5831,

title = "Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis",

abstract = "Worldwide, more than 400 million individuals have allergic rhinitis, which has a significant impact on the individual's general health. Most patients self-medicate with over-the-counter drugs, but severe cases need treatment with topical corticosteroids and/or immunotherapy (SCIT). Although the ARIA guidelines discourage the use of systemic corticosteroids, this treatment is often used by general practitioners.",

author = "Kristian Aasbjerg and C Torp-Pedersen and V Backer",

note = "{\textcopyright} 2012 John Wiley & Sons A/S.",

year = "2012",

doi = "10.1111/all.12023",

language = "English",

volume = "67",

pages = "1423--9",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley Online",

number = "11",

}

RIS

TY - JOUR

T1 - Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis

AU - Aasbjerg, Kristian

AU - Torp-Pedersen, C

AU - Backer, V

PY - 2012

Y1 - 2012

N2 - Worldwide, more than 400 million individuals have allergic rhinitis, which has a significant impact on the individual's general health. Most patients self-medicate with over-the-counter drugs, but severe cases need treatment with topical corticosteroids and/or immunotherapy (SCIT). Although the ARIA guidelines discourage the use of systemic corticosteroids, this treatment is often used by general practitioners.

AB - Worldwide, more than 400 million individuals have allergic rhinitis, which has a significant impact on the individual's general health. Most patients self-medicate with over-the-counter drugs, but severe cases need treatment with topical corticosteroids and/or immunotherapy (SCIT). Although the ARIA guidelines discourage the use of systemic corticosteroids, this treatment is often used by general practitioners.

U2 - 10.1111/all.12023

DO - 10.1111/all.12023

M3 - Journal article

C2 - 22984787

VL - 67

SP - 1423

EP - 1429

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 11

ER -

ID: 48420676